92972-37-7 Usage
Explanation
The molecular formula represents the number of atoms of each element present in a molecule of the compound.
2. Derivative of Naphthyridine Family
Explanation
It is a chemical compound derived from the naphthyridine family, which is a group of nitrogen-containing heterocyclic compounds.
3. Contains Carboxylic Acid Group
Explanation
The compound has a carboxylic acid functional group (-COOH) attached to the 3rd carbon atom of the naphthyridine ring.
4. Contains Hydroxyl Group
Explanation
The compound has a hydroxyl functional group (-OH) attached to the 4th carbon atom of the naphthyridine ring.
5. Used in Synthesis of Pharmaceuticals and Research Chemicals
Explanation
The compound is utilized as a building block or starting material in the synthesis of various pharmaceuticals and research chemicals due to its unique chemical structure.
6. Potential Applications in Drug Development
Explanation
Its unique chemical structure and properties make it a candidate for the development of new drugs and pharmaceutical formulations.
7. Chemical Intermediate in Organic Synthesis
Explanation
The compound can be used as a chemical intermediate in the production of various other compounds through organic synthesis.
8. 9CI Designation
Explanation
The "9CI" in the name stands for "Chemical Abstracts Service Registry Number," which is a unique identifier assigned to chemical compounds in the Chemical Abstracts database.
Check Digit Verification of cas no
The CAS Registry Mumber 92972-37-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,9,7 and 2 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 92972-37:
(7*9)+(6*2)+(5*9)+(4*7)+(3*2)+(2*3)+(1*7)=167
167 % 10 = 7
So 92972-37-7 is a valid CAS Registry Number.
92972-37-7Relevant academic research and scientific papers
Polysubstituted quinolone compounds, and preparation method and use thereof
-
Paragraph 0131; 0132; 0133; 0547; 0548; 0549, (2017/09/19)
The invention provides polysubstituted quinolone compounds, and a preparation method and a use thereof, and concretely provides a polysubstituted quinolone compound represented by formula I, and optical isomers, pharmaceutically acceptable salts or solvates thereof. All groups in the formula I are defined in the description. The quinolone compound has excellent c-Met inhibition activity, and can be used for treating c-Met activity or expression level corrected diseases.
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
-
Page/Page column 64-65, (2009/04/25)
The present invention relates to modulators of ATP-B inding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates
